FDA Approves Generic Suboxone Sublingual Film for Opioid Dependence Treatment

On June 14, 2018, FDA approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for treating opioid dependence. The approval was granted to Mylan Technologies and Dr. Reddy's Laboratories, who will market buprenorphine and naloxoOriginal Article